Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BeiGene, Ltd. - American Depositary Shares (NQ:ONC)

242.60 -2.98 (-1.21%)
Streaming Delayed Price Updated: 10:20 AM EDT, Jun 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,259
Open 243.45
Bid (Size) 241.62 (3)
Ask (Size) 243.59 (2)
Prev. Close 245.58
Today's Range 240.00 - 248.00
52wk Range 172.67 - 287.88
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025
From BeOne Medicines Ltd.
Via Business Wire
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025
From BeOne Medicines Ltd.
Via Business Wire

Performance

YTD
+31.8%
+31.8%
1 Month
-2.7%
-2.7%
3 Month
-6.1%
-6.1%
6 Month
+31.8%
+31.8%
1 Year
+31.8%
+31.8%

More News

Read More
Earnings Preview: BeiGene
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology
From BeOne Medicines Ltd.
Via Business Wire
BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Nasopharyngeal Cancer
From BeiGene, Ltd.
Via Business Wire
BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors
From BeiGene, Ltd.
Via Business Wire
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Via The Motley Fool
Topics Economy Law Enforcement
Exposures Economy Legal Product Safety
BeiGene Showcases Strength of Hematology Portfolio at EHA 2025 with New Data Highlighting BRUKINSA’s Leadership and Next-Generation Innovation
From BeiGene, Ltd.
Via Business Wire
Earnings Scheduled For May 14, 2025
Via Benzinga
BeiGene to Present at the RBC Capital Markets Global Healthcare Conference
From BeiGene, Ltd.
Via Business Wire
Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat
Via Benzinga
BeiGene Announces First Quarter 2025 Financial Results and Business Updates
From BeiGene, Ltd.
Via Business Wire
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene
From BeiGene, Ltd.
Via Business Wire
Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back
Via Benzinga
Summit Therapeutics Retail Traders Stoked As Stock Surges On Promising Cancer Drug Trial
Via Stocktwits
Why Is Summit Therapeutics Stock Soaring On Wednesday?
Via Benzinga
BeiGene to Announce First Quarter 2025 Financial Results on May 7
From BeiGene, Ltd.
Via Business Wire
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
Via Benzinga
Forecasting The Future: 4 Analyst Projections For BeiGene
Via Benzinga
This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit
Via Benzinga
BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
From BeiGene, Ltd.
Via Business Wire
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is BeiGene, Ltd. - American Depositary Shares publicly traded?
Yes, BeiGene, Ltd. - American Depositary Shares is publicly traded.
What exchange does BeiGene, Ltd. - American Depositary Shares trade on?
BeiGene, Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BeiGene, Ltd. - American Depositary Shares?
The ticker symbol for BeiGene, Ltd. - American Depositary Shares is ONC on the Nasdaq Stock Market
What is the current price of BeiGene, Ltd. - American Depositary Shares?
The current price of BeiGene, Ltd. - American Depositary Shares is 242.60
When was BeiGene, Ltd. - American Depositary Shares last traded?
The last trade of BeiGene, Ltd. - American Depositary Shares was at 06/02/25 10:20 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.